Kiran Mazumdar-Shaw On Regulation-Innovation Imbalance, Biocon's Weight-Loss Drug Bet

India's bio-economy is heading towards $250 billion by 2030, but the country's regulatory system is not keeping pace with innovation, thereby impeding growth, according to Kiran Mazumdar-Shaw."Regulation in India has not kept pace with innovation. It takes twice or thrice as long to develop novel molecules in India compared to Europe or the U.S.," the Biocon Ltd. founder and chairperson told NDTV Profit, in an exclusive interview.Ind...